rs79263074

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_152743.4(BRAT1):​c.679C>T​(p.Arg227Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000571 in 1,582,498 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R227H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00061 ( 17 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

10
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.89

Publications

1 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010544121).
BP6
Variant 7-2543714-G-A is Benign according to our data. Variant chr7-2543714-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 472977.
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.000606 (866/1430166) while in subpopulation EAS AF = 0.0217 (847/38984). AF 95% confidence interval is 0.0205. There are 17 homozygotes in GnomAdExome4. There are 403 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.679C>T p.Arg227Cys missense_variant Exon 5 of 14 ENST00000340611.9 NP_689956.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.679C>T p.Arg227Cys missense_variant Exon 5 of 14 1 NM_152743.4 ENSP00000339637.4

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152214
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00674
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000415
AC:
98
AN:
236080
AF XY:
0.000322
show subpopulations
Gnomad AFR exome
AF:
0.0000625
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00527
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000944
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000606
AC:
866
AN:
1430166
Hom.:
17
Cov.:
33
AF XY:
0.000571
AC XY:
403
AN XY:
706138
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32960
American (AMR)
AF:
0.00
AC:
0
AN:
43150
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24786
East Asian (EAS)
AF:
0.0217
AC:
847
AN:
38984
South Asian (SAS)
AF:
0.0000359
AC:
3
AN:
83514
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51792
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5648
European-Non Finnish (NFE)
AF:
0.00000825
AC:
9
AN:
1090468
Other (OTH)
AF:
0.000119
AC:
7
AN:
58864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000249
AC:
38
AN:
152332
Hom.:
0
Cov.:
31
AF XY:
0.000309
AC XY:
23
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41582
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00675
AC:
35
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000529
Hom.:
2
Bravo
AF:
0.0000831
ExAC
AF:
0.000527
AC:
64
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Feb 21, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported previously in an individual with Dravet syndrome; however, a second BRAT1 variant was not identified, and the patient was found to have a variant in the SCN1A gene (Kim et al., 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29295803) -

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Dec 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.012
T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.088
D
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
1.9
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-2.9
D
REVEL
Uncertain
0.44
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.048
D
Polyphen
1.0
D
Vest4
0.16
MVP
0.93
MPC
0.30
ClinPred
0.081
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.093
gMVP
0.14
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79263074; hg19: chr7-2583348; COSMIC: COSV61396339; COSMIC: COSV61396339; API